-
Declining resources in the face of increasing demand are causing sexually transmitted infection (STI) clinics to review new strategies to maximize efficiency without compromising quality of care.
-
New research indicates that provision of effective contraception at the time of postpartum follow-up is a key strategy for achieving optimal interpregnancy intervals.
-
The American College of Obstetricians and Gynecologists says that long-acting reversible contraception (LARC) methods are safe, effective, and appropriate options for teens, but some might perceive high discontinuation rates among younger women and therefore steer patients away from them.
-
Transdermal contraception provides a family planning option that is not dependent on daily dosing. The only transdermal contraceptive approved in the United States is the Ortho Evra patch.
-
No link seen between regimen use and increased sexual risk behavior
-
Early research indicates that women with moderate to severe menstrual cramps might find relief in vaginal administration of sildenafil citrate (Viagra, Pfizer), a drug commonly used for erectile dysfunction.
-
With Congress in a seemingly perpetual state of deadlock, one of the most anticipated actions on federal reproductive health policy will instead be taken by the U.S. Supreme Court this spring.
-
Compared to normal women and women with endometriosis without chronic pain, women with chronic pelvic pain demonstrate increased pain sensitivity at nonpelvic sites.
-
A new study shows that using cervical length as an arbiter of whom to admit for suspected preterm labor is a safe and cost-effective method to decrease health care costs.
-
In this national cohort study, 13% of women undergoing gynecologic surgery where antibiotics were recommended received no antibiotics or the incorrect antibiotics.
